Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/4/2025

Management of Hypertension in Patients with Horseshoe Kidney

Initial Assessment and Diagnosis

  • Conduct thorough blood pressure measurement using validated devices with appropriate cuff size, taking multiple readings and averaging them to confirm hypertension (≥140/90 mmHg in office or ≥135/85 mmHg on home monitoring) 1
  • Assess for target organ damage with particular attention to renal function (eGFR, albuminuria/proteinuria), as recommended by the American Heart Association 1, 2
  • Calculate cardiovascular risk using appropriate risk calculators, as suggested by the American College of Cardiology 1

Diagnostic Workup and Monitoring

  • Obtain basic metabolic panel to assess kidney function and electrolytes, as recommended by the National Kidney Foundation 3
  • Measure urine albumin-to-creatinine ratio to detect early kidney damage, as suggested by the American Heart Association 2
  • Schedule follow-up visits every 6-8 weeks until BP goal is achieved, with laboratory evaluation of kidney function and electrolytes, as recommended by the American Journal of Kidney Diseases 3

Treatment Approach and Blood Pressure Goals

  • Target blood pressure should be <130/80 mmHg given the presence of chronic kidney disease (horseshoe kidney), as recommended by the American College of Cardiology and the American Heart Association 2, 4
  • Implement lifestyle modifications including sodium restriction (<2g sodium/day), regular physical activity (150 minutes/week of moderate-intensity exercise), weight management if overweight/obese, limited alcohol consumption, and DASH-style diet rich in fruits, vegetables, and low-fat dairy, as suggested by the American Heart Association 1

Pharmacological Management and Special Considerations

  • Begin with an ACE inhibitor or ARB as first-line therapy due to their renoprotective effects beyond BP lowering, as recommended by the American College of Cardiology and the American Heart Association 2, 4
  • Monitor kidney function and potassium levels within 2-4 weeks after initiation of ACE inhibitors or ARBs, as suggested by the American Journal of Kidney Diseases 3
  • For patients with horseshoe kidney and significant proteinuria (≥300 mg/day), ACE inhibitors or ARBs are strongly recommended for their antiproteinuric effects, as recommended by the American College of Cardiology 4
  • Be cautious with aggressive BP lowering in patients who may have orthostatic hypotension; test for this by measuring BP after 5 minutes of sitting/lying and then 1-3 minutes after standing, as suggested by the European Heart Journal 6
  • Monitor closely for acute kidney injury when initiating RAS blockers, especially if there's a possibility of renal artery stenosis, as recommended by the European Heart Journal 7